Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review

被引：0

作者：

Montserrat León-García

Brittany Humphries

Andrea Maraboto

Montserrat Rabassa

Kasey R. Boehmer

Lilisbeth Perestelo-Perez

Feng Xie

Irene Pelayo

Mark Eckman

Shannon Bates

Anna Selva

Pablo Alonso-Coello

机构：

[1] Biomedical Research Institute Sant Pau (IIB Sant Pau),Department of Pediatrics, Obstetrics, Gynaecology and Preventive Medicine

[2] Universidad Autónoma de Barcelona,Knowledge and Evaluation Research Unit, Department of Medicine

[3] Mayo Clinic,Department of Health Research Methods, Evidence and Impact

[4] Cytel Inc,Division of Health Care Delivery Research

[5] McMaster University,Evaluation Unit (SESCS)

[6] Mayo Clinic,Network for Research On Chronicity

[7] Canary Islands Health Service (SCS),Centre for Health Economics and Policy Analysis

[8] Research Network On Health Services in Chronic Diseases (REDISSEC),Department of Obstetrics and Gynecology

[9] Primary Care,Faculty of Medicine

[10] and Health Promotion (RICAPPS),Division of General Internal Medicine and Center for Clinical Effectiveness

[11] McMaster University,Department of Medicine

[12] Ramón y Cajal Hospital,Clinical Epidemiology and Cancer Screening

[13] Alcalá de Henares University, CIBER of Epidemiology and Public Health

[14] University of Cincinnati School of Medicine,undefined

[15] McMaster University,undefined

[16] Corporació Sanitaria Parc Taulí,undefined

[17] CIBERESP,undefined

来源：

BMC Pregnancy and Childbirth | / 22卷

关键词：

Venous thromboembolism; Low-molecular-weight-heparin; Pregnancy; Values and preferences;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 196 条

[1]

Bailly J(2019)Safety and efficacy of adjusted-dose enoxaparin in pregnant patients with increased risk for venous thromboembolic disease Int J Gynaecol and Obstet 145 70-75

[2]

Jacobson BF(2018)The prevalence of thrombophilia in women with recurrent fetal loss and outcome of anticoagulation therapy for the prevention of miscarriages Clin Appl Thromb/Hemost 24 122-128

[3]

Louw S(2019)Critical appraisal of international guidelines for the prevention and treatment of pregnancy-associated venous thromboembolism: a systematic review BMC Cardiovasc Disord 19 1-10

[4]

Nahas R(2013)Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature J Thromb Haemost 11 270-281

[5]

Saliba W(2020)Prophylaxis and therapy of venous thrombotic events in pregnancy and the postpartum period GebFra Science 80 48-59

[6]

Elias A(2014)Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications Blood 123 822-828

[7]

Elias M(2017)Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: is it time to put the needles away? Thromb Res 151 S38-42

[8]

Zheng J(2018)The society for obstetric anesthesia and perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants Anesth Analg 126 928-944

[9]

Chen Q(2012)Patient values and preferences in decision making for antithrombotic therapy: a systematic review - antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines Chest 141 e1S-e23S

[10]

Fu J(2018)American society of hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy Blood Adv 2 3317-3359

← 1 2 3 4 5 6 7 8 9 10 →